polyestradiol
Trade name: Estradurin
Small moleculeapproved
Approved
Apr 17, 1957
Clinical trial activity
0 trials · 0 clinical orgs · 1 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1950s
- Apr 17, 1957
Earliest FDA Approval
- Apr 17, 1957
American Home Products — NDA Secondary Org
Indications
Approved for
Mechanism of action
- Estrogen receptor alphaAGONIST
ESR1 agonist
Approval history
- approvedApr 17, 1957
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- Yes
- Delivery
- Parenteral
- Availability
- Discontinued
Oral
No
Parenteral
Yes
Topical
No
Sources
- NCATSP14877CDX2 ↗
- ChEMBLCHEMBL1201477 ↗
Also known as
- estra-1,3,5(10)-triene-3,17 diol (17-beta)-, polymer with phosporic acid
- estradiol phosphate polymer
- estradurin
- estradurin
- estradurin
- estradurin
- estradurin
- estradurine
- leo-114
- leo-114
- polyest phos
- polyestradiol
- polyestradiol
- polyestradiol phosphate
- polyestradiol phosphate
- polyestradiol phosphate
- polyestradiol phosphate
- polyestradiol phosphate
- polyestradiol phosphate
- polyestradiol phos phosphate
- polyestrol phosphate
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| American Home Products | For profit | NDA | — |
| American Home Products | For profit | NDA2 | Apr 17, 1957 |